Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis

BackgroundPostoperative depression (POD) represents a serious complication in surgical patients, exacerbating morbidity and mortality rates while imposing a substantial economic burden on healthcare systems. Despite its widespread clinical use, the role of esketamine, an NMDA receptor antagonist wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao-Yan Li, Wen-Jing Xu, Ya-Mei Wang, Shuang Xie, Huan-Liang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Psychiatry
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1476449/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187503015821312
author Hao-Yan Li
Wen-Jing Xu
Ya-Mei Wang
Shuang Xie
Huan-Liang Wang
author_facet Hao-Yan Li
Wen-Jing Xu
Ya-Mei Wang
Shuang Xie
Huan-Liang Wang
author_sort Hao-Yan Li
collection DOAJ
description BackgroundPostoperative depression (POD) represents a serious complication in surgical patients, exacerbating morbidity and mortality rates while imposing a substantial economic burden on healthcare systems. Despite its widespread clinical use, the role of esketamine, an NMDA receptor antagonist with rapid antidepressant effects, remains understudied in perioperative settings. Therefore, we conducted a systematic review and meta-analysis to assess the efficacy of esketamine on postoperative depression. To evaluate the effect of esketamine on the incidence and severity of postoperative depression in different types of surgery by randomized controlled trial, investigate whether esketamine can effectively reduce the postoperative depression score and the incidence of postoperative depression in the short and long term after use, to promote the application of perioperative analgesia-antidepressant combination.MethodSearched PubMed, the Cochrane Library, the Web of Science, and Medline to identify randomized controlled trials using the drug of esketamine and analyzed the data using Review Manager 5.3.ResultsWe included a total of 8 randomized controlled trials involving 1724 patients who met the criteria. The meta-analysis revealed that esketamine treatment, compared with control groups, significantly reduced POD. Improvements were observed at 1 week (RD -0.09, 95% CI [-0.13, -0.05], P < 0.0001, I²=84%), 2 weeks (RD -0.08, 95% CI [-0.13, -0.03], P < 0.00001, I²=97%), and long-term follow-up (RD -0.06, 95% CI [-0.10, -0.02], P=0.0002, I²=79%).ConclusionEsketamine demonstrates efficacy in reducing POD incidence and severity, although its use is associated with an increased risk of adverse effects. Also, the method of drug injection, the duration of administration and the number of doses may have an effect on the results. Therefore, further exploration of appropriate dosing regimens and multi-modal strategies is necessary to mitigate adverse effects.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024506329.
format Article
id doaj-art-0fb4e65a0e0b43e38810122d03f831d4
institution OA Journals
issn 1664-0640
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Psychiatry
spelling doaj-art-0fb4e65a0e0b43e38810122d03f831d42025-08-20T02:16:05ZengFrontiers Media S.A.Frontiers in Psychiatry1664-06402025-04-011610.3389/fpsyt.2025.14764491476449Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysisHao-Yan LiWen-Jing XuYa-Mei WangShuang XieHuan-Liang WangBackgroundPostoperative depression (POD) represents a serious complication in surgical patients, exacerbating morbidity and mortality rates while imposing a substantial economic burden on healthcare systems. Despite its widespread clinical use, the role of esketamine, an NMDA receptor antagonist with rapid antidepressant effects, remains understudied in perioperative settings. Therefore, we conducted a systematic review and meta-analysis to assess the efficacy of esketamine on postoperative depression. To evaluate the effect of esketamine on the incidence and severity of postoperative depression in different types of surgery by randomized controlled trial, investigate whether esketamine can effectively reduce the postoperative depression score and the incidence of postoperative depression in the short and long term after use, to promote the application of perioperative analgesia-antidepressant combination.MethodSearched PubMed, the Cochrane Library, the Web of Science, and Medline to identify randomized controlled trials using the drug of esketamine and analyzed the data using Review Manager 5.3.ResultsWe included a total of 8 randomized controlled trials involving 1724 patients who met the criteria. The meta-analysis revealed that esketamine treatment, compared with control groups, significantly reduced POD. Improvements were observed at 1 week (RD -0.09, 95% CI [-0.13, -0.05], P < 0.0001, I²=84%), 2 weeks (RD -0.08, 95% CI [-0.13, -0.03], P < 0.00001, I²=97%), and long-term follow-up (RD -0.06, 95% CI [-0.10, -0.02], P=0.0002, I²=79%).ConclusionEsketamine demonstrates efficacy in reducing POD incidence and severity, although its use is associated with an increased risk of adverse effects. Also, the method of drug injection, the duration of administration and the number of doses may have an effect on the results. Therefore, further exploration of appropriate dosing regimens and multi-modal strategies is necessary to mitigate adverse effects.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024506329.https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1476449/fullesketaminepostoperativedepressionanesthesiameta-analysis
spellingShingle Hao-Yan Li
Wen-Jing Xu
Ya-Mei Wang
Shuang Xie
Huan-Liang Wang
Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
Frontiers in Psychiatry
esketamine
postoperative
depression
anesthesia
meta-analysis
title Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
title_full Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
title_fullStr Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
title_full_unstemmed Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
title_short Efficacy of perioperative esketamine on postoperative depression: a systematic review and meta-analysis
title_sort efficacy of perioperative esketamine on postoperative depression a systematic review and meta analysis
topic esketamine
postoperative
depression
anesthesia
meta-analysis
url https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1476449/full
work_keys_str_mv AT haoyanli efficacyofperioperativeesketamineonpostoperativedepressionasystematicreviewandmetaanalysis
AT wenjingxu efficacyofperioperativeesketamineonpostoperativedepressionasystematicreviewandmetaanalysis
AT yameiwang efficacyofperioperativeesketamineonpostoperativedepressionasystematicreviewandmetaanalysis
AT shuangxie efficacyofperioperativeesketamineonpostoperativedepressionasystematicreviewandmetaanalysis
AT huanliangwang efficacyofperioperativeesketamineonpostoperativedepressionasystematicreviewandmetaanalysis